Water Street Healthcare Partners Closes $650 Million Private Equity Fund Healthtorial

Water Street Healthcare Partners Closes $650 Million Private Equity Fund  Healthtorial

Water Street Healthcare Partners Closes $650 Million Private Equity Fund

Water Street Healthcare Partners, a private equity firm focused exclusively on the health care industry, announced the closing of its second independent private equity fund, Water Street Healthcare Partners II, L.P. The fund closed at its cap of $650 million of investor commitments, exceeding its original target of $600 million, and bringing the firm’s total capital under management to more than $1 billion.

“We are pleased that our limited partners continue to support our focused investment strategy,” said Tim Dugan, founding and managing partner of Water Street. “Their strong response enabled us to raise our fund quickly. We are grateful for their recognition of the results our firm has achieved over the past two years. Our team’s deep expertise in health care, disciplined approach to identifying proprietary opportunities and demonstrated ability to transform businesses into market-leadership companies has been, and will continue to be, core to our success.”

Water Street has completed 10 proprietary investments and announced one additional investment since raising its first fund approximately two years ago. The firm was founded by Jim Connelly, the former president and COO of Caremark International, Tim Dugan and Kip Kirkpatrick, who, together, previously led health care investments for One Equity Partners, the $5.5 billion private equity arm of JP Morgan Chase.

Consistent with Water Street’s first fund, the firm’s second fund will focus on creatively partnering with middle-market companies and divisions of global companies in attractive health care sectors with opportunities for growth. The firm recently announced its first investment for Fund II through a partnership with Gentiva Health Services, Inc. to acquire a controlling stake in CareCentrix, the largest manager of home health care services for managed care organizations. Water Street has partnered with global health care companies, such as Gentiva, Medtronic, Inc. and Matria Healthcare, Inc. to divest lower-priority businesses for nearly half of its investments. It also has partnered with founders and CEOs of middle-market companies to strategically expand their businesses.

“Water Street has consistently built companies of significant value in attractive segments of health care,” said Brett Johnson, principal, Pantheon Ventures, Inc. “The firm has a proven track record and a unique approach to originating investment opportunities. We believe Water Street’s combination of industry expertise and operational experience in the growing health care market ideally positions the firm for continued success.”

Investors in Water Street’s fund are a combination of leading domestic and international pension funds, endowments, financial institutions and fund-of-funds, including: Adams Street Partners, Allianz Private Equity Partners, Goldman Sachs Asset Management and New York Life Capital Partners. Water Street’s second fund also attracted new investors, including: Soros Strategic Partners LP, Blue Cross Blue Shield of Arizona, Danske Private Equity, as well as leading university endowments and foundations.

“We are honored to partner with such a highly regarded and distinguished group of investors,” said Kip Kirkpatrick, a founding partner of Water Street. “Health care continues to be an outstanding opportunity for investment as one of the largest and most profitable industries in the U.S. Over the past two years, we have built an exceptional investment team with extensive backgrounds in operating global health care businesses. We believe our deep expertise and extensive network of industry contacts will continue to drive our ability to build companies of long-lasting value and superior returns for our investors.”

Water Street will continue to pursue investments in six key segments of health care, including: diagnostic devices, medical products, pharmaceutical services, specialty distribution, specialty pharmaceuticals and specialty services. Its transactions typically range from $50 million to $500 million in value.

Tags: brett johnson, caremark international, funding, gentiva health services, jim connelly, JP morgan chase, kip kirkpatrick, matria healthcare, medtronic, one equity partners, pantheon ventures, tim dugan, Water Street Healthcare Partners

You can use these XHTML tags

« Two Studies Refine Risks and Predictors for Advanced Macular Degeneration

Health Costs and Insurance Claims Less for Morbidly Obese after Bariatric Surgery »

LatestCategoriesRandomTagsHealth Costs and Insurance Claims Less for Morbidly Obese after Bariatric Surgery

Water Street Healthcare Partners Closes $650 Million Private Equity Fund

Two Studies Refine Risks and Predictors for Advanced Macular Degeneration

Mediplay Makes Marketing More Profitable for Physicians

Quick and Easy Patient Alert ID

Safeway Raises $9.7 Million to Fight Muscular Dystrophy

Cardiovascular Sciences Bursts Upon the Nutritional Supplement Market

California is About to Know the Ugly Truth

Stanford Medical School Takes the Hard Line

New Findings with SaltA Call for Food SafetySafeway Raises $9.7 Million to Fight Muscular DystrophyNew Long-Term Prospective Study of Statin Drugs Confirms Utility To Reduce Risk of Dementia and Memory LossTo 10 Health Systems: U.S. Most Unpopular - Dutch - Most PopularHealthy Food in WattsMarket for Artificial Disc Replacement Products to Grow by Over 40% through 2013 Reaching $440 MillionStop Diabetes BEFORE it StartsLuminaries Call For Ending AIDS through a VaccineVeterans Helping VeteransHealth